https://www.avient.com/sites/default/files/2023-10/31307-Certificate-20SEP2023.pdf
Activity: Manufacture of Colorants for Plastics Activity: Manufacture of thermoplastic compounds Page 4 of 7 ABS Quality Evaluations Avient Corporation ISO 9001:2015 Certificate Of Conformance ANNEX At Below Facilities: Validity of this certificate may be confirmed at www.abs-qe.com/cert_validation.
https://www.avient.com/sites/default/files/2024-10/Compensation Committee Charter - Final.pdf
• With the assistance of management and any outside advisers the Committee deems appropriate (a) review and discuss with management the Company’s disclosures in the CD&A, and, based on this review, make a recommendation as to whether to include it in the Company’s annual report on Form 10-K and proxy statement relating to the Company’s annual meeting of shareholders, and (b) prepare a Compensation Committee Report for inclusion in the Company’s proxy statement or other applicable SEC filings. 4 Board Reports and Annual Evaluation. • Regularly report the Committee’s activities and any recommendations to the Board in such manner and at such times as the Committee or the Board deems appropriate. • Conduct an annual evaluation of the Committee’s performance.
https://www.avient.com/sites/default/files/2022-05/MEVOPUR LQ for Silicone Elastomers_CN.pdf
在不限制本声明的一般性的情况下，不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4) 用于支持或维持人类生命的永久性（超过30天）植入式医疗器械中的任何关键组件。
https://www.avient.com/sites/default/files/2022-07/MEVOPUR Chemical Foaming Agents Application Bulletin_CN.pdf
在不限制本声明的一般性的情况下，不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4) 用于支持或维持人类生命的永久性（超过30天）植入式医疗器械中的任何关键组件。
https://www.avient.com/sites/default/files/2022-07/REMAFIN EP White Masterbatches for Pharma Application Bulletin_CN.pdf
在不限制本声明的一般性的情况下，不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4) 用于支持或维持人类生命的永久性（超过30天）植入式医疗器械中的任何关键组件。
https://www.avient.com/sites/default/files/2022-05/Compensation Committee Charter (REV 10-2019).pdf
• With the assistance of management and any outside advisers the Committee deems appropriate (a) review and discuss with management the Company’s disclosures in the CD&A, and, based on this review, make a recommendation as to whether to include it in the Company’s annual report on Form 10-K and proxy statement relating to the Company’s annual meeting of shareholders, and (b) prepare a Compensation Committee Report for inclusion in the Company’s proxy statement or other applicable SEC filings. 4 Board Reports and Annual Evaluation. • Regularly report the Committee’s activities and any recommendations to the Board in such manner and at such times as the Committee or the Board deems appropriate. • Conduct an annual evaluation of the Committee’s performance.
https://www.avient.com/sites/default/files/2022-10/PREPERM_for_5G_Application_Bulletin_CN10.8-2.pdf
在很宽的频率范围仍保持稳定的射频性能 0,0 2,0 4,0 6,0 8,0 10,0 12,0 0 10 20 30 40 50 60 D ie le ct ri c co ns ta nt F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 生产过程中批次间的稳定性 * 2018 年芬兰有限公司VTT技术研究中心测量数据 介 电 常 数 损 耗 因 数 介 电 常 数 频率 [GHz] 频率 [GHz] 分批编号 （1250 kg/批次） PREPERM™ PPE950 PREPERM™ PPE800 PREPERM™ PPE440 PREPERM™ PPE320 PREPERM™ PPE260 -- 目标介电常数 -- +/- 2% 3,76 3,78 3,80 3,82 3,84 3,86 3,88 3,90 3,92 3,94 0 1 2 3 4 5 6 7 8 D ie le ct ri c co ns ta nt P a llet number (1250 k g/pa llet ) Die le ctric cons ta nt ta rge t +/- 2 % 0,000 0,002 0,004 0,006 0,008 0,010 0 10 20 30 40 50 60 Lo ss t a ng en t F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 0,000 0,002 0,004 0,006 0,008 0,010 0 10 20 30 40 50 60 Lo ss t a ng en t F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 0,000 0,002 0,004 0,006 0,008 0,010 0 10 20 30 40 50 60 Lo ss t a ng en t F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 1.844.4AVIENT www.avient.com 版权所有©2022 埃万特公司。
https://www.avient.com/sites/default/files/2020-08/2020-composite-springs-product-selection-install-guide.pdf
TYPICAL PROPERTIES Sample thickness 0.25 in/6.35mm TEMPERATURE FLEXURAL STRENGTH ASTM D790 FLEXURAL MODULUS ASTM D790 °F °C ksi MPa msi GPa -60 -51 173 1193 5.00 34.48 70 21 155 1069 5.11 35.23 160 71 138 952 5.04 34.75 250 121 110 758 4.70 32.41 300 149 78 538 4.22 29.10 -60 -51 176 1211 5.64 38.92 70 21 143 989 5.36 36.98 160 71 120 824 5.57 38.41 250 121 61 423 4.82 33.24 -60 -51 163 1125 4.19 28.88 70 21 120 824 3.85 26.51 160 71 86 595 3.83 26.44 250 121 40 274 3.19 22.00 Gl as s/ Ep ox y H ig h Te m p Ep ox y/ Gl as s Gl as s/ Vi ny l E st er MECHANICAL PERFORMANCE TESTING NOTES Springs were fatigue tested at 4 hz in a cantilevered loading.
https://www.avient.com/sites/default/files/resources/TRA%2520-%25202016%2520Plan%2520Summary.pdf
Comments Website address where the Plan Summary is posted for the public File Name * Date * TRA Plan Certifications.pdf 30/04/2018 4:22:30 PM Plan Summary Submission Electronic Submission Company Name Polyone Canada Inc.
https://www.avient.com/sites/default/files/2022-04/Avient Announces Agreement to Acquire Dyneema_0.pdf
# # # http://www.avient.com/investors https://edge.media-server.com/mmc/p/edkwvu9r https://edge.media-server.com/mmc/p/edkwvu9r http://www.avient.com/investors https://www.avient.com/ 4 Forward-looking Statements In this press release, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.